Full history for every metric is available with a Kvantra account
ZimVie Inc. (ZIMV)
Key financial summary
Financials in USD| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Total revenue | $m | 1,056 | 912 | 1,015 | 914 | 457 | 450 | 443 |
| Operating profit | $m | -21 | -9 | |||||
| Net profit | $m | -28 | -179 | -95 | -64 | -393 | -26 | -19 |
| EPS reported | $ | -0.94 | -0.70 | |||||
| Operating cashflow per share | $ | 0.52 | 0.52 | |||||
| Capex per share | $ | 0.24 | 0.24 | |||||
| FCF per share | $ | 0.27 | 0.27 | |||||
| Free cash flow | $m | 7 | 6 | |||||
| Net debt | $m | 145 | 151 | |||||
| Book value equity | $m | 382 | 413 | |||||
| Book value per share | $ | 13.93 | 14.74 | |||||
| Number of shares | m | 27.4 | 28 | |||||
| DPS (TTM paid) | $ | 0.00 | 0.00 |
Financial summary
Financials in USD| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM | ||
|---|---|---|---|---|---|---|---|---|
| Value | ||||||||
| P/E TTM | x | - | - | |||||
| P/B LTM | x | 1.00 | 1.30 | |||||
| P/S LTM | x | 0.85 | 1.21 | |||||
| P/FCF LTM | x | 51.02 | 95.38 | |||||
| EV/EBITDA LTM | x | 18.23 | 16.00 | |||||
| EV/Sales LTM | x | 1.20 | 1.55 | |||||
| Earnings Yield LTM | % | -6.76% | -4.96% | |||||
| FCF Yield | % | 1.96% | 1.05% | |||||
| Quality | ||||||||
| ROE | % | -6.77% | -6.53% | |||||
| ROIC | % | -3.31% | -3.31% | |||||
| Operating margin | % | -4.59% | -4.59% | |||||
| Gross margin | % | 63.91% | 63.91% | |||||
| FCF/Sales | % | 1.67% | 1.67% | |||||
| Growth and momentum | ||||||||
| EPS Growth YoY | % | - | - | |||||
| Sales Growth YoY | % | -1.68% | -19.52% | |||||
| Net Income Growth YoY | % | - | - | |||||
| FCF Growth | % | -69.62% | -77.37% | |||||
| Operating Profit Growth | % | - | - | |||||
| Dividend and capital structure | ||||||||
| Dividend Yield | % | 0.00% | 0.00% | |||||
| Dividend Growth | % | 0.00% | 0.00% | |||||
| Payout Ratio | % | 0.00% | 0.00% | |||||
| FCF/Debt | x | 0.03 | 0.02 | |||||
| Net Debt/EBITDA | x | 5.32 | 5.32 | |||||
| EBIT/Net interest | x | -1.09 | -1.09 | |||||
| Net debt/market cap | % | 38.06% | 28.12% | |||||
| Net debt/Equity | x | 0.38 | 0.36 | |||||
| Gross debt/equity | x | 0.61 | 0.57 | |||||
Company overview
ZimVie Inc. operates as a medical technology enterprise, specializing in the design, manufacturing, and global distribution of an extensive array of products and solutions. These offerings are engineered to address various spinal conditions and facilitate dental tooth replacement and restorative procedures. Its comprehensive dental portfolio encompasses implant systems, along with associated prosthetic and abutment components, and the necessary surgical instrumentation and kits. The company also supplies advanced regenerative products such as bone grafts, barrier membranes, allografts, and collagen-based wound care solutions. Furthermore, it provides cutting-edge digital dentistry tools, including intraoral scanners, virtual treatment planning services, guided surgery capabilities, CAD/CAM workflow systems, and customized restorative parts. In the spinal segment, ZimVie offers a range of fusion implants and specialized instrumentation for diverse surgical interventions, including biologics and innovative bone healing technologies. Notably, its specialized spinal offerings include minimally invasive surgery (MIS) solutions, exemplified by products like Vital MIS and Timberline, as well as advanced motion preservation technologies such as Mobi-C and The Tether. Established in 2021, ZimVie Inc. maintains its corporate headquarters in Westminster, Colorado.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
ZimVie Inc. (ZIMV)
ZimVie Inc. operates as a medical technology enterprise, specializing in the design, manufacturing, and global distribution of an extensive array of products and solutions. These offerings are engineered to address various spinal conditions and facilitate dental tooth replacement and restorative procedures. Its comprehensive dental portfolio encompasses implant systems, along with associated prosthetic and abutment components, and the necessary surgical instrumentation and kits. The company also supplies advanced regenerative products such as bone grafts, barrier membranes, allografts, and collagen-based wound care solutions. Furthermore, it provides cutting-edge digital dentistry tools, including intraoral scanners, virtual treatment planning services, guided surgery capabilities, CAD/CAM workflow systems, and customized restorative parts. In the spinal segment, ZimVie offers a range of fusion implants and specialized instrumentation for diverse surgical interventions, including biologics and innovative bone healing technologies. Notably, its specialized spinal offerings include minimally invasive surgery (MIS) solutions, exemplified by products like Vital MIS and Timberline, as well as advanced motion preservation technologies such as Mobi-C and The Tether. Established in 2021, ZimVie Inc. maintains its corporate headquarters in Westminster, Colorado.
Unlock all fundamental data
Sign up for FreeUnlock all fundamental data
Sign up for Free